Optimind Pharma Corp. (CSE:OMND)
 0.0050
 -0.0050 (-50.00%)
  Aug 19, 2025, 1:59 PM EDT
Optimind Pharma Company Description
Optimind Pharma Corp. provides psychedelic therapies in Canada.
The company offers psychedelic-like therapies for the treatment of post-traumatic stress syndrome, anxiety, depression, and other mental illnesses and disabilities through ketamine-assisted treatment and other psychedelic enhanced psychotherapy modalities.
It also prescribes medical cannabis and other alternative treatments for various medical ailments through its clinics.
Optimind Pharma Corp. is headquartered in Toronto, Canada.
Optimind Pharma Corp.
  | Country | Canada | 
| Industry | Drug Manufacturers - Specialty & Generic | 
| Sector | Healthcare | 
| CEO | David Goodman | 
Contact Details
| Address: 40 King Street West Toronto, Ontario M5H 3Y2 Canada | |
| Phone | 647-891-9379 | 
| Website | optimindpharma.com | 
Stock Details
| Ticker Symbol | OMND | 
| Exchange | Canadian Securities Exchange | 
| Fiscal Year | March - February | 
| Reporting Currency | CAD | 
| ISIN Number | CA68405U1012 | 
| SIC Code | 8000 | 
Key Executives
| Name | Position | 
|---|---|
| David Goodman | Chief Executive Officer | 
| Rakesh Malhotra | Chief Financial Officer |